Angiodynamics (ANGO) Free Cash Flow (2016 - 2026)
Angiodynamics' Free Cash Flow history spans 17 years, with the latest figure at -$3.6 million for Q1 2026.
- For Q1 2026, Free Cash Flow rose 74.93% year-over-year to -$3.6 million; the TTM value through Feb 2026 reached $1.2 million, up 104.31%, while the annual FY2025 figure was -$14.6 million, 52.43% up from the prior year.
- Free Cash Flow reached -$3.6 million in Q1 2026 per ANGO's latest filing, down from $3.4 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $18.0 million in Q2 2025 to a low of -$27.0 million in Q3 2022.
- Average Free Cash Flow over 5 years is -$3.7 million, with a median of -$110000.0 recorded in 2023.
- Peak YoY movement for Free Cash Flow: surged 248.66% in 2022, then crashed 12413.64% in 2024.
- A 5-year view of Free Cash Flow shows it stood at $6.3 million in 2022, then plummeted by 35.92% to $4.0 million in 2023, then tumbled by 67.49% to $1.3 million in 2024, then surged by 157.68% to $3.4 million in 2025, then crashed by 206.79% to -$3.6 million in 2026.
- Per Business Quant, the three most recent readings for ANGO's Free Cash Flow are -$3.6 million (Q1 2026), $3.4 million (Q4 2025), and -$16.6 million (Q3 2025).